Prognostic value of left ventricular global constructive work in patients with cardiac amyloidosis

Maron BJ et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart failure and transplantation committee; quality of Care and Outcomes Research and Functio. Circulation 113:1807–1816. doi: https://doi.org/10.1161/CIRCULATIONAHA.106.174287

Article  Google Scholar 

Wechalekar AD, Gillmore JD, Hawkins PN “Systemic amyloidosis,” The Lancet, vol. 387, no. 10038. Lancet Publishing Group, pp. 2641–2654, Jun. 25, 2016, doi: https://doi.org/10.1016/S0140-6736(15)01274-X

Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS (2019) “Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review,” Journal of the American College of Cardiology, vol. 73, no. 22. Elsevier USA, pp. 2872–2891, Jun. 11, doi: https://doi.org/10.1016/j.jacc.2019.04.003

Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C (2017) “Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis,” Circulation, vol. 135, no. 14, pp. 1357–1377, Apr. doi: https://doi.org/10.1161/CIRCULATIONAHA.116.024438

Sperry BW, Saeed IM, Raza S, Kennedy KF, Hanna M, Spertus JA (2019) “Increasing Rate of Hospital Admissions in Patients With Amyloidosis (from the National Inpatient Sample),” Am. J. Cardiol, vol. 124, no. 11, pp. 1765–1769, Dec. doi: https://doi.org/10.1016/j.amjcard.2019.08.045

Ruberg FL, Berk JL (2012) “Transthyretin (TTR) cardiac amyloidosis,” Circulation, vol. 126, no. 10. Lippincott Williams & WilkinsHagerstown, MD, pp. 1286–1300, Sep. 04, doi: https://doi.org/10.1161/CIRCULATIONAHA.111.078915

Korosoglou G et al (2021) “Diagnostic work-up of cardiac amyloidosis using cardiovascular imaging: Current standards and practical algorithms,” Vascular Health and Risk Management, vol. 17. Dove Medical Press Ltd, pp. 661–673, doi: https://doi.org/10.2147/VHRM.S295376

Dorbala S et al (Dec. 2019) ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base and standardized methods of imaging. J Nucl Cardiol 26(6):2065–2123. doi: https://doi.org/10.1007/s12350-019-01760-6

Ternacle J et al (Feb. 2016) Causes and consequences of longitudinal LV dysfunction assessed by 2D strain Echocardiography in Cardiac Amyloidosis. JACC Cardiovasc Imaging 9(2):126–138. doi: https://doi.org/10.1016/j.jcmg.2015.05.014

Cho GY, Marwick TH, Kim HS, Kim MK, Hong KS, Oh DJ (2009) “Global 2-Dimensional Strain as a New Prognosticator in Patients With Heart Failure,” J. Am. Coll. Cardiol, vol. 54, no. 7, pp. 618–624, Aug. doi: https://doi.org/10.1016/j.jacc.2009.04.061

Pagourelias ED et al (Mar. 2017) Echo Parameters for Differential diagnosis in Cardiac Amyloidosis: a Head-to-Head comparison of deformation and nondeformation parameters. Circ Cardiovasc Imaging 10(3). doi: https://doi.org/10.1161/CIRCIMAGING.116.005588

Donal E et al (2009) “Influence of afterload on left ventricular radial and longitudinal systolic functions: A two-dimensional strain imaging study,” Eur. J. Echocardiogr, vol. 10, no. 8, pp. 914–921, doi: https://doi.org/10.1093/ejechocard/jep095

Boe E, Skulstad H, Smiseth OA (2019) “Myocardial work by echocardiography: a novel method ready for clinical testing,” Eur. Hear. J. - Cardiovasc. Imaging, vol. 20, no. 1, pp. 18–20, Jan. doi: https://doi.org/10.1093/ehjci/jey156

Russell K et al (2012) “A novel clinical method for quantification of regional left ventricular pressurestrain loop area: A non-invasive index of myocardial work,” Eur. Heart J, vol. 33, no. 6, pp. 724–733, doi: https://doi.org/10.1093/eurheartj/ehs016

Garcia-Pavia P et al (2021) “Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases,” Eur. Heart J, vol. 42, no. 16, pp. 1554–1568, doi: https://doi.org/10.1093/eurheartj/ehab072

Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1–39. doi: https://doi.org/10.1016/j.echo.2014.10.003

Article  Google Scholar 

Voigt JU et al (Jan. 2015) Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 16(1):1–11. doi: https://doi.org/10.1093/ehjci/jeu184

Chan J et al (Jan. 2019) A new approach to assess myocardial work by non-invasive left ventricular pressure-strain relations in hypertension and dilated cardiomyopathy. Eur Heart J Cardiovasc Imaging 20(1):31–39. doi: https://doi.org/10.1093/ehjci/jey131

Knight DS et al (May 2019) Cardiac structural and functional consequences of amyloid deposition by Cardiac magnetic resonance and Echocardiography and their prognostic roles. JACC Cardiovasc Imaging 12(5):823–833. doi: https://doi.org/10.1016/j.jcmg.2018.02.016

Vecera J et al (2016) “Wasted septal work in left ventricular dyssynchrony: A novel principle to predict response to cardiac resynchronization therapy,” Eur. Heart J. Cardiovasc. Imaging, vol. 17, no. 6, pp. 624–632, doi: https://doi.org/10.1093/ehjci/jew019

Boe E et al (2015) “Non-invasive myocardial work index identifies acute coronary occlusion in patients with non-ST-segment elevation-acute coronary syndrome,” Eur. Hear. J. – Cardiovasc. Imaging, vol. 16, no. 11, pp. 1247–1255, doi: https://doi.org/10.1093/ehjci/jev078

Roger-Rollé A et al (2020) “Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?,” Open Hear, vol. 7, no. 2, p. 1346, doi: https://doi.org/10.1136/openhrt-2020-001346

Clemmensen TS et al (May 2021) Prognostic implications of left ventricular myocardial work indices in cardiac amyloidosis. Eur Hear J - Cardiovasc Imaging 22(6):695–704. doi: https://doi.org/10.1093/ehjci/jeaa097

Henein MY, Lindqvist P (2021) “Myocardial work does not have additional diagnostic value in the assessment of attr cardiac amyloidosis,” J. Clin. Med, vol. 10, no. 19, p. 10, Oct. doi: https://doi.org/10.3390/jcm10194555

Galli E et al (Jan. 2019) Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis. Echocardiography 36(1):74–82. doi: https://doi.org/10.1111/echo.14210

Stassen J et al (Sep. 2022) Left ventricular myocardial work to differentiate cardiac amyloidosis from hypertrophic cardiomyopathy. J Am Soc Echocardiogr. doi: https://doi.org/10.1016/j.echo.2022.08.015

Yingchoncharoen T, Agarwal S, Popović ZB, Marwick TH (2013) “Normal ranges of left ventricular strain: A meta-analysis,” J. Am. Soc. Echocardiogr, vol. 26, no. 2, pp. 185–191, Feb. doi: https://doi.org/10.1016/j.echo.2012.10.008

Manganaro R et al (2019) Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study. Eur Hear Journal-Cardiovascular Imaging 20:582–590. doi: https://doi.org/10.1093/ehjci/jey188

Article  Google Scholar 

留言 (0)

沒有登入
gif